Logo-jcvtr

J Cardiovasc Thorac Res. 2014;6(4): 257-259. doi: 10.15171/jcvtr.2014.022
PMID: 25610559        PMCID: PMC4291606

Short Communication

Effects of Intravenous Indomethacin on Reduction of Symptomatic Patent Ductus Arteriosus Cases and Decreasing the Need for Prolonged Mechanical Ventilation

Abdollah Jannatdoust 1, Mahmoud Samadi 1, Saadollah Yeganehdoust 1, Mohammad Heydarzadeh 1, Hossein Alikhah 1, Mohammad Naghavi-Behzad 2,3 *

Cited by CrossRef: 3


1- Mitra S, Gardner C, MacLellan A, Disher T, Styranko D, Campbell-Yeo M, Kuhle S, Johnston B, Dorling J. Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis. 2022;2022(4) [Crossref]
2- Mitra S, Scrivens A, von Kursell A, Disher T. Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants. 2020;2020(12) [Crossref]
3- Jansen E, Hundscheid T, Onland W, Kooi E, Andriessen P, de Boode W. Factors Associated With Benefit of Treatment of Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-Analysis. Front Pediatr. 2021;9 [Crossref]